Source: Thermo Fisher Scientific Form 10-Q and Form 10-K, Note, Disaggregated Revenues, Revenues by business, BioProduction (USD millions). Q1 2024 $590 and Q1 2025 $671: Q1 2025 10-Q https://www.sec.gov/Archives/edgar/data/97745/000009774525000041/tmo-20250329.htm. Q2 2024 $633 and Q2 2025 $745: Q2 2025 10-Q https://www.sec.gov/Archives/edgar/data/97745/000009774525000101/tmo-20250628.htm. Q3 2024 $680, Q3 2025 $817, nine-month 2024 $1,903, nine-month 2025 $2,234: Q3 2025 10-Q https://www.sec.gov/Archives/edgar/data/97745/000009774525000159/tmo-20250927.htm. FY 2024 $2,652 and FY 2025 $3,200: FY 2025 10-K https://www.sec.gov/Archives/edgar/data/97745/000009774526000018/tmo-20251231.htm. Q1 2026 $893: Q1 2026 10-Q https://www.sec.gov/Archives/edgar/data/97745/000009774526000092/tmo-20260328.htm. Q2 2026 $941 and Q2 2025 $745: Q2 2026 10-Q https://www.sec.gov/Archives/edgar/data/97745/000009774526000144/. Q3 2026 $896 and Q3 2025 $817: Q3 2026 10-Q https://www.sec.gov/Archives/edgar/data/97745/000009774526000179/tmo-20260926.htm.

Source: Thermo Fisher Scientific Form 10-Q and Form 10-K, Note, Disaggregated Revenues, Revenues by business, Clinical research (USD millions). Q1 2024 $2,033 and Q1 2025 $1,939: Q1 2025 10-Q https://www.sec.gov/Archives/edgar/data/97745/000009774525000041/tmo-20250329.htm. Q2 2024 $1,949 and Q2 2025 $1,955: Q2 2025 10-Q https://www.sec.gov/Archives/edgar/data/97745/000009774525000101/tmo-20250628.htm. Q3 2024 $1,956, Q3 2025 $2,019, nine-month 2024 $5,938, nine-month 2025 $5,914: Q3 2025 10-Q https://www.sec.gov/Archives/edgar/data/97745/000009774525000159/tmo-20250927.htm. FY 2024 $7,836 and FY 2025 $7,915: FY 2025 10-K https://www.sec.gov/Archives/edgar/data/97745/000009774526000018/tmo-20251231.htm. Q1 2026 $2,128: Q1 2026 10-Q https://www.sec.gov/Archives/edgar/data/97745/000009774526000092/tmo-20260328.htm. Q2 2026 $2,396 and Q2 2025 $1,955: Q2 2026 10-Q https://www.sec.gov/Archives/edgar/data/97745/000009774526000144/. Q3 2026 $2,445 and Q3 2025 $2,019: Q3 2026 10-Q https://www.sec.gov/Archives/edgar/data/97745/000009774526000179/tmo-20260926.htm. Clario close March 24, 2026 and Q3 2026 MD&A $425 million reported growth: same Q3 2026 10-Q.

Source: Thermo Fisher Scientific Form 10-Q and Form 10-K, contract-related balances (USD millions). Q4 2023 current $2,689 / noncurrent $1,499 and Q4 2024 $2,852 / $1,138: FY 2024 10-K https://www.sec.gov/Archives/edgar/data/97745/000009774525000010/tmo-20241231.htm. Q1 2024 $2,632 / $1,427: Q1 2024 10-Q https://www.sec.gov/Archives/edgar/data/97745/000009774524000023/tmo-20240330.htm. Q2 2024 $2,591 / $1,455: Q2 2024 10-Q https://www.sec.gov/Archives/edgar/data/97745/000009774524000040/tmo-20240629.htm. Q3 2024 $2,663 / $1,428: Q3 2024 10-Q https://www.sec.gov/Archives/edgar/data/97745/000009774524000046/tmo-20240928.htm. Q1 2025 $2,866 / $1,127: Q1 2025 10-Q https://www.sec.gov/Archives/edgar/data/97745/000009774525000041/tmo-20250329.htm. Q2 2025 $2,805 / $1,122: Q2 2025 10-Q https://www.sec.gov/Archives/edgar/data/97745/000009774525000101/tmo-20250628.htm. Q3 2025 $2,852 / $1,159: Q3 2025 10-Q https://www.sec.gov/Archives/edgar/data/97745/000009774525000159/tmo-20250927.htm. Q4 2025 $2,710 / $1,183: FY 2025 10-K https://www.sec.gov/Archives/edgar/data/97745/000009774526000018/tmo-20251231.htm. Q1 2026 $2,928 / $1,034: Q1 2026 10-Q https://www.sec.gov/Archives/edgar/data/97745/000009774526000092/tmo-20260328.htm. Q2 2026 $2,918 / $1,043: Q2 2026 10-Q https://www.sec.gov/Archives/edgar/data/97745/000009774526000144/. Q3 2026 $2,941 / $1,084: Q3 2026 10-Q https://www.sec.gov/Archives/edgar/data/97745/000009774526000179/tmo-20260926.htm.

Source: Thermo Fisher Scientific Form 10-Q and Form 10-K, Note, Disaggregated Revenues, Revenues by business, Pharma services (USD millions). Q1 2024 $1,578 and Q1 2025 $1,607: Q1 2025 10-Q https://www.sec.gov/Archives/edgar/data/97745/000009774525000041/tmo-20250329.htm. Q2 2024 $1,627 and Q2 2025 $1,794: Q2 2025 10-Q https://www.sec.gov/Archives/edgar/data/97745/000009774525000101/tmo-20250628.htm. Q3 2024 $1,647, Q3 2025 $1,722, nine-month 2024 $4,852, nine-month 2025 $5,123: Q3 2025 10-Q https://www.sec.gov/Archives/edgar/data/97745/000009774525000159/tmo-20250927.htm. FY 2024 $6,685 and FY 2025 $7,142: FY 2025 10-K https://www.sec.gov/Archives/edgar/data/97745/000009774526000018/tmo-20251231.htm. Q1 2026 $1,741: Q1 2026 10-Q https://www.sec.gov/Archives/edgar/data/97745/000009774526000092/tmo-20260328.htm. Q2 2026 $1,893 and Q2 2025 $1,794: Q2 2026 10-Q https://www.sec.gov/Archives/edgar/data/97745/000009774526000144/. Q3 2026 $2,029 and Q3 2025 $1,722: Q3 2026 10-Q https://www.sec.gov/Archives/edgar/data/97745/000009774526000179/tmo-20260926.htm.

Source: Thermo Fisher Scientific Form 10-Q and Form 10-K, remaining performance obligations (us-gaap:RevenueRemainingPerformanceObligation, consolidated undimensioned context, retrieved from the SEC XBRL company-concept API). Fiscal quarters ended September 30, 2023 through September 26, 2026. Q3 2026 $29.87 billion: Q3 2026 10-Q https://www.sec.gov/Archives/edgar/data/97745/000009774526000179/tmo-20260926.htm.

Source: Thermo Fisher Scientific Form 10-Q and Form 10-K, Note, Disaggregated Revenues, Revenues by business, Research and safety market channel (USD millions). Q1 2024 $1,711 and Q1 2025 $1,727: Q1 2025 10-Q https://www.sec.gov/Archives/edgar/data/97745/000009774525000041/tmo-20250329.htm. Q2 2024 $1,775 and Q2 2025 $1,883: Q2 2025 10-Q https://www.sec.gov/Archives/edgar/data/97745/000009774525000101/tmo-20250628.htm. Q3 2024 $1,739, Q3 2025 $1,861, nine-month 2024 $5,225, nine-month 2025 $5,471: Q3 2025 10-Q https://www.sec.gov/Archives/edgar/data/97745/000009774525000159/tmo-20250927.htm. FY 2024 $7,019 and FY 2025 $7,440: FY 2025 10-K https://www.sec.gov/Archives/edgar/data/97745/000009774526000018/tmo-20251231.htm. Q1 2026 $1,827: Q1 2026 10-Q https://www.sec.gov/Archives/edgar/data/97745/000009774526000092/tmo-20260328.htm. Q2 2026 $2,036 and Q2 2025 $1,883: Q2 2026 10-Q https://www.sec.gov/Archives/edgar/data/97745/000009774526000144/. Q3 2026 $2,030 and Q3 2025 $1,861: Q3 2026 10-Q https://www.sec.gov/Archives/edgar/data/97745/000009774526000179/tmo-20260926.htm.